Innovative Research

Innovative Research

img-03
img-02

INNOVATIVE RESEARCH

Through Innovative Research, we have been always identifying various novel products with IP strength with the help of the Pharma database. We are continuously filing applications for patents in India and in the USA.

As a versatile CRO, we have been able to help our clients address the challenges of innovation and regulatory risk with the ongoing development of Novel or 505(b)(2) new drug candidates. We are able to offer process development, CMC, and pharmacovigilance to suit our customers’ needs.

  • Change in the Route of Administration
  • New Molecular Entity (NME)
  • Product Lifecycle Management
  • Platform Technologies
  • 505(b)2
  • Unmet Medical Needs
  • Market Exclusivity
PATENTS / PCTs.

Our patent is a legal document that gives Zenvision Pharma the exclusive right to make, use, and sell an invention for a certain number of years. At Zenvision, patents are used to protect our new drug manufacturing and formulation innovations.

Zenvison PHarma is an established and trustworthy CRO with a distinct vertical devoted to developing truly novel or 505(b)(2) formulations. Zenvision has submitted over 40 patent applications (31 India, 9 PCT, 5 USA, 2 EU). Innovative projects are being developed for both regulated markets (the United States and Europe) and ROW markets.

  • Zenvision has developed Platform Technologies to extend the Product Life Cycle for certain off-patent products.
  • Zenvision has unique formulations for unmet medical needs.
  • Capability and knowledge base for handling Cytotoxic, Anti-neoplastic, and Hormones products in addition to regular products.
  • Zenvision has developed products that are potential candidates for 505b2
img-03
img-02

INNOVATIVE RESEARCH

We have been always identifying various novel products with IP strength with the help of the Pharma database. We are continuously filing applications for patents in India and in the USA.

As a versatile CRO, we have been able to help our clients address the challenges of innovation and regulatory risk with the ongoing development of Novel or 505(b)(2) new drug candidates. We are able to offer process development, CMC, and pharmacovigilance to suit our customers’ needs.

PATENTS / PCTs.

Our patent is a legal document that gives Zenvision Pharma the exclusive right to make, use, and sell an invention for a certain number of years. At Zenvision, patents are used to protect our new drug manufacturing and formulation innovations.

Zenvison PHarma is an established and trustworthy CRO with a distinct vertical devoted to developing truly novel or 505(b)(2) formulations. Zenvision has submitted over 40 patent applications (31 India, 9 PCT, 5 USA, 2 EU). Innovative projects are being developed for both regulated markets (the United States and Europe) and ROW markets.

  • Zenvision has developed Platform Technologies to extend the Product Life Cycle for certain off-patent products.
  • Zenvision has unique formulations for unmet medical needs.
  • Capability and knowledge base for handling Cytotoxic, Anti-neoplastic, and Hormones products in addition to regular products.
  • Zenvision has developed products that are potential candidates for 505b2